Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Joseph V Pergolizzi$suffix/text()$suffix/text(), Robert Taylor$suffix/text()$suffix/text() & Robert B Raffa. (2011) Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opinion on Pharmacotherapy 12:11, pages 1757-1768.
Read now
Read now
Monika Vij, Dudley Robinson & Linda Cardozo. (2010) Emerging drugs for treatment of urinary incontinence. Expert Opinion on Emerging Drugs 15:2, pages 299-308.
Read now
Read now
Articles from other publishers (13)
Naoki Ishitsubo, Shinji Oguro, Hirotoshi Shimahashi, Masato Kawanishi, Takeshi Adachi, Kenji Mitsuda & Nobuyuki Ishibashi. (2023) Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration. European Journal of Drug Metabolism and Pharmacokinetics.
Crossref
Crossref
Joseph F. Goldberg, Michael Q. Steinman & Stephen M. Stahl. (2023) Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability. Neuroscience Applied 2, pages 101127.
Crossref
Crossref
Shinichi Kawai, Satoshi Sobajima, Masashi Jinnouchi, Hideshi Nakano, Hideaki Ohtani, Mineo Sakata & Takeshi Adachi. (2022) Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study. Clinical Drug Investigation 42:5, pages 403-416.
Crossref
Crossref
Marie Shigematsu-Locatelli, Takashi Kawano, Tsuyoshi Koyama, Hideki Iwata, Atsushi Nishigaki, Bun Aoyama, Hiroki Tateiwa, Noriko Kitaoka & Masataka Yokoyama. (2019) Therapeutic experience with tramadol for opioid dependence in a patient with chronic low back pain: a case report. JA Clinical Reports 5:1.
Crossref
Crossref
Marta Ondrésik, Fatima R. Azevedo Maia, Alain da Silva Morais, Ana C. Gertrudes, Ana H. Dias Bacelar, Cristina Correia, Cristiana Gonçalves, Hajer Radhouani, Rui Amandi Sousa, Joaquim M. Oliveira & Rui L. Reis. (2017) Management of knee osteoarthritis. Current status and future trends. Biotechnology and Bioengineering 114:4, pages 717-739.
Crossref
Crossref
Sybil Skinner-Robertson, Caroline Fradette, Sylvie Bouchard, Mohamad-Samer Mouksassi & France Varin. (2015) Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects. Drugs & Aging 32:12, pages 1029-1043.
Crossref
Crossref
Chiara Angeletti, Cristiana Guetti, Antonella Paladini & Giustino Varrassi. (2013) Tramadol Extended-Release for the Management of Pain due to Osteoarthritis. ISRN Pain 2013, pages 1-16.
Crossref
Crossref
Shinri Takasuga, Rie Yamamoto, Shoichi Mafune, Chiyo Sutoh, Katsuya Kominami, Yoshimasa Yoshida, Masao Ito & Mine Kinoshita. (2011) In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic. Journal of Pharmacy and Pharmacology 63:11, pages 1437-1445.
Crossref
Crossref
PHILIP J. MEASE, SYLVIA HANNA, ELIJAH P. FRAKES & ROY D. ALTMAN. (2011) Pain Mechanisms in Osteoarthritis: Understanding the Role of Central Pain and Current Approaches to Its Treatment: Figure 1.. The Journal of Rheumatology 38:8, pages 1546-1551.
Crossref
Crossref
David Karhu, Caroline Fradette, Maria Alida Potgieter, Maria M. Ferreira & Johann Terblanché. (2013) Comparative Pharmacokinetics of a Once‐Daily Tramadol Extended‐Release Tablet and an Immediate‐Release Reference Product Following Single‐Dose and Multiple‐Dose Administration. The Journal of Clinical Pharmacology 50:5, pages 544-553.
Crossref
Crossref
Walter F. Kean, Sylvie Bouchard & E. Roderich Gossen. (2009) Women with Pain due to Osteoarthritis: The Efficacy and Safety of a Once-Daily Formulation of Tramadol. Pain Medicine 10:6, pages 1001-1011.
Crossref
Crossref
Karl-Erik Andersson. (2009) Prospective pharmacologic therapies for the overactive bladder. Therapeutic Advances in Urology 1:2, pages 71-83.
Crossref
Crossref
Mats Karlsson & Anna-Carin Berggren. (2009) Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clinical Therapeutics 31:3, pages 503-513.
Crossref
Crossref